Viemed Healthcare, Inc. VMD
NASDAQ · United States · Health Services
$9.05-0.05 (-0.55%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.Under applicable securities laws, insiders are subject to limits on their ability to sell shares.
Viemed Healthcare’s updated analyst model now places fair value at $12.50, compared with the previous $11.00 estimate, which signals a reset in how the stock is being framed. Supportive analysts link this change to Viemed Healthcare’s position in home respiratory care and its exposure to a broader mix of equipment, while more cautious voices point to near term profitability pressures and a tighter margin of safety. As you read on, you will see how these shifting views shape the evolving...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.